Genetics and the British insurance industry

Area of Science:

• Bioethics
• Insurance Law
• Genetic Policy

Background:

• Genetic testing advancements create ethical dilemmas concerning insurance and employment.
• Public and governmental concerns prompted the British insurance industry to address genetic information privacy.
• The potential for genetic discrimination impacts equitable risk pooling in insurance.

Purpose of the Study:

• To examine the development of the British insurance industry's code of practice regarding genetic information.
• To explore issues of genetic discrimination, medical information access, and consent.
• To analyze the implications of genetic data for insurance risk assessment and equity.

Main Methods:

• Historical analysis of the British insurance industry's response to genetic testing.
• Review of ethical considerations, including consent and information disclosure.
• Examination of the impact on insurance principles like pooled risk.

Main Results:

• The Association of British Insurers proactively developed a code of practice.
• Key issues discussed include genetic discrimination, data privacy, and informed consent.
• The industry's approach emphasizes ethical considerations and self-regulation.

Conclusions:

• The British insurance industry's code of practice represents a proactive, ethically-driven response to genetic testing.
• Moral reflection and industry-led initiatives are presented as the preferred path forward, rather than legislative mandates.
• The development highlights the complex interplay between genetic information, individual rights, and insurance market stability.